Address: Beijing's xizhimen south street, xicheng district
The British garden 1 floor. Room 824
Zip code: 100035
Telephone: 010-58562339
Fax: 010-58562339
Email address: cngjzj@163.com
Web site (click on the url link directly left) :
http://www.cngjzj.com/
Blog (click on the url link directly left) :
http://blog.sina.com.Cn/CNGJZJ
To xizhimen south street, xicheng district building to the British garden route
L airport line 1
Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.
L airport line 2
From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.
L bus subway near:
106 bus GuanYuan: 107 road, express way
Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road
Che zhuang: subway line two
Xizhimen subway: metro line 2
Buses and attempts: 107 road, 118 road, 701 road
Buses and north zhuang: 209 road, 375 road, 392 road
2017年08月24日
China's traditional Chinese medicine resources protection and scientific and technological innovation have achieved remarkable results
Time: 2017-08-24
Source: Chinese medical journal
Author: Chen zhizhi
Report from our correspondent (reporter Chen meter wisdom) reporter held on August 18, from the 16th Chinese medicine union meeting understands, globalization in recent years, around the Chinese medicine resources protection and utilization in our country, vigorously promote scientific and technological innovation and national cooperation, carried out a lot of fruitful work.
The resources of traditional Chinese medicine are becoming more and more clear. From 2011 to 2016, we completed the investigation of the traditional Chinese medicine resources in more than 900 counties. Protected TCM firing technology, has been in the national construction 54 concocted inheritance of the traditional Chinese medicine national medicine base, organize a group of endangered processing technology, strengthen the integration between the traditional processing enterprises and the mass production.
Lead to improve the quality of traditional Chinese medicine source protection, insist on innovation, conducted from Chinese medicines, medicinal materials and Chinese medicines sliced and prepared for decoction and the quality of the whole chain safeguard scientific research, strengthen the protection and utilization of wild endangered drug resources, standardize the traditional Chinese medicine (TCM) the seed seedling breeding, planting management field of agricultural production such as the management of the key links.
The standardization of traditional Chinese medicine is accelerated, the standardization of traditional Chinese medicine is actively promoted, the protection of intellectual property of traditional Chinese medicine is strengthened, and the quality and efficiency of Chinese medicine industry is promoted.
The international cooperation and internationalization of traditional Chinese medicine are progressing well, and our experts should invite the government of Cambodia to guide the protection of local drug resources. At the invitation of the Lao government, he assisted Laos in completing the resource investigation of more than 600 drugs in seven provinces and compiling works such as the Lao traditional medicine Chronicles. So far, salvia miltiorrhiza, and nine varieties of 32 quality standards adopted by the American pharmacopoeia formally, 24 varieties of Chinese traditional medicine is under review and examination and approval of the United States pharmacopoeia committee, five kinds of Chinese herbal medicine income American dietary supplements, contains four kinds of Chinese herbal medicine by the European pharmacopoeia, 9 kinds of Chinese medicinal materials by French pharmacopoeia records, three varieties of Chinese patent medicine is registered successfully in the European Union; The FDA is also gradually improving its guidelines for regulation and development of Chinese medicine.